Trump health secretary nominee Rep. Tom Price accused of insider trading in Congress
Rep. Tom Price (R-Ga.), Donald Trump's nominee for health and human services secretary, invested between $1,000 and $15,000 in medical device manufacturer Zimmer Biomet last March, less than a week before introducing legislation that would greatly benefit the company, CNN reports, citing House records. Less than three months after Price introduced the HIP Act, which would have delayed implementation of a regulation to change how Medicare paid and reimbursed hip and knee implant manufacturers and providers, Zimmer Biomet's PAC sent Price's re-election committee a $1,000 check; the company's PAC had also sent Price's campaign a $1,000 check two days after he fruitlessly wrote the Medicare administrator urging him to delay implementation of the rule, CNN says.
Trump transition spokesman Phil Blando said Price wasn't aware of the transaction, apparently executed by a broker, until weeks after Price had introduced the legislation, and "any effort to connect the introduction of bipartisan legislation by Dr. Price to any campaign contribution is demonstrably false." Senate Minority Leader Chuck Schumer (D-N.Y.) suggested that Price may have violated the 2012 STOCK Act, a law designed to combat insider trading by members of Congress with special knowledge of coming legislation. "The president-elect claims he wants to drain the swamp, but Congressman Price has spent his career filling it up," Schumer said. Last month, The Wall Street Journal reported that over the past four years, Price has traded about $300,000 in shares in health companies while pursuing legislation that could affect the companies.
Price may have had entirely pure motives in his stock transactions, but "it clearly has the appearance of using your influence as a congressman to your financial benefit," says ethics law expert Larry Noble at watchdog group the Campaign Legal Center. "When you join the government, you are held to a higher standard. And you are supposed to work for the public and not for yourself." Price will likely be asked about the Zimmer Biomet trade and other transactions at his confirmation hearing this week and next.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
The new powers to stop stalking in the UK
The Explainer Updated guidance could help protect more victims, but public is losing trust in police and battered criminal justice system
By Harriet Marsden, The Week UK Published
-
'Criminal trail?'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Grindr 'shared user HIV status' with ad firms, lawsuit claims
Speed Read LGBTQ dating app accused of breaching UK data protection laws in case filed at London's High Court
By Rebecca Messina, The Week UK Published
-
Empty-nest boomers aren't selling their big homes
Speed Read Most Americans 60 and older do not intend to move, according to a recent survey
By Peter Weber, The Week US Published
-
Brazil accuses Musk of 'disinformation campaign'
Speed Read A Brazilian Supreme Court judge has opened an inquiry into Elon Musk and X
By Rafi Schwartz, The Week US Published
-
Disney board fends off Peltz infiltration bid
Speed Read Disney CEO Bob Iger has defeated activist investor Nelson Peltz in a contentious proxy battle
By Rafi Schwartz, The Week US Published
-
Disney and DeSantis reach detente
Speed Read The Florida governor and Disney settle a yearslong litigation over control of the tourism district
By Peter Weber, The Week US Published
-
Visa and Mastercard agree to lower swipe fees
Speed Read The companies will cap the fees they charge businesses when customers use their credit cards
By Peter Weber, The Week US Published
-
Reddit IPO values social media site at $6.4 billion
Speed Read The company makes its public debut on the New York Stock Exchange
By Peter Weber, The Week US Published
-
Housing costs: the root of US economic malaise?
speed read Many voters are troubled by the housing affordability crisis
By Peter Weber, The Week US Published
-
Feds cap credit card late fees at $8
speed read The Consumer Financial Protection Bureau finalized a rule to save households an estimated $10 billion a year
By Peter Weber, The Week US Published